Current management of delta hepatitis

Liver International

Volumn 33, Issue SUPPL. 1, 2013, Pages 195-197

  Rizzetto, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic hepatitis D; Hepatitis D therapy; Hepatitis D virus; Hepatitis therapy; Interferon; Peg interferon

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; INTERFERON; LAMIVUDINE; MYRCLUDEX B; PEGINTERFERON; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PLACEBO; UNCLASSIFIED DRUG; VIRUS DNA;

COMBINATION CHEMOTHERAPY; DELTA AGENT HEPATITIS; DRUG MEGADOSE; END STAGE LIVER DISEASE; HEPATITIS DELTA VIRUS; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MONOTHERAPY; NONHUMAN; PRENYLATION; REINFECTION; REVIEW; SURVIVAL RATE; TREATMENT RESPONSE; VIRAL CLEARANCE; VIREMIA; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; INTERFERON-ALPHA; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84872012503     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12058     Document Type: Review

References (18)

1. Engelke M, Mills K, Seitz S, et al. Characterization of a hepatitis B and hepatitis delta virus receptor-binding site. Hepatology 2006; 43: 750-60.
2. Taylor JM. Replication of the hepatitis delta virus RNA genome. Adv Virus Res 2009; 74: 103-21.
3. Lai MM. RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol 2005; 79: 7951-8.
4. Ponzetto A, Hoyer BH, Popper H, et al. Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis 1987; 155: 72-8.
5. Niro GA, Rosina F, Rizzetto M. Treatment of hepatitis D. J Viral Hepat 2005; 12: 2-9.
6. Wedemeyer H, Yurdaydìn C, Dalekos GN, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011; 364: 322-31.
7. Aziz S, Rajper J, Noor-Ul-Ain W, et al. Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection. J Coll Physicians Surg Pak 2011; 21: 735-40.
8. Yurdaydin C, Bozkaya H, Karaaslan H, et al. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis. J Viral Hepat 2007; 14: 812-6.
9. Castelnau C, Le Gal F, Ripault MP, et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006; 44: 728-35.
10. Erhardt A, Gerlich W, Starke C, et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int 2006; 26: 805-10.
11. Niro GA, Ciancio A, Gaeta GB, et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 2006; 44: 713-20.
12. Gheorghe L, Iacob S, Simionov I, et al. Weight-based dosing regimen of Peg-Interferon α-2b for chronic hepatitis delta: a multicenter Romanian trial. J Gastrointestin Liver Dis 2011; 20: 377-82.
13. Yurdaydin C, Kabacam G, Cakaloglu Y, et al. Efficacy of pegylated interferon-based treatment in patients with cirrhosis due to chronic delta hepatitis: comparison with non-cirrhotic patients (AASLD abstract). Hepatology 2009; 50(Suppl. 4): 736A.
14. Lütgehetmann M, Mancke LV, Volz T, et al. Human chimeric uPA mouse model to study hepatitis B and D virus interactions and preclinical drug evaluation. Hepatology 2012; 55: 685-94.
15. Glenn JS. Prenylation of HDAg and antiviral drug development. Curr Top Microbiol Immunol 2006; 307: 133-49.
16. Samuel D, Forns X, Berenguer M, et al. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). J Hepatol 2006; 45: 127-43.
17. Franchello A, Ghisetti V, Marzano A, Romagnoli R, Salizzoni M. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection. Liver Transpl 2005; 11: 922-8.
18. Bahde R, Hölzen JP, Wolters HH, et al. Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient. Ann Hepatol 2011; 10: 355-60.